www.fdanews.com/articles/74165-accentia-biopharma-cuts-ipo-price-to-8-10-share
ACCENTIA BIOPHARMA CUTS IPO PRICE TO $8-$10/SHARE
July 11, 2005
Drug developer Accentia Biopharmaceuticals Inc. filed with regulators on Monday to cut the expected price of its planned initial public offering to $8 to $10 per share, from $11 to $13 per share. According to an amended prospectus filed with the U.S. Securities and Exchange Commission, Accentia plans to sell up to 5.25 million shares in the offering, and stockholders will sell an additional 1 million shares.